3/18
07:26 pm
abcl
AbCellera Biologics Eyes Integrated Biotech Shift; ABCL635 Phase II Data Due in Q3 at Forum [Yahoo! Finance]
Neutral
Report
AbCellera Biologics Eyes Integrated Biotech Shift; ABCL635 Phase II Data Due in Q3 at Forum [Yahoo! Finance]
3/4
12:04 pm
abcl
AbCellera Biologics Pivots to Pipeline as ABCL635 Phase II Hot Flash Data Nears, Exec Says [Yahoo! Finance]
Low
Report
AbCellera Biologics Pivots to Pipeline as ABCL635 Phase II Hot Flash Data Nears, Exec Says [Yahoo! Finance]
2/26
04:14 pm
abcl
AbCellera Biologics (ABCL) Pivots to Clinical Stage as 2025 Revenue Hits $75M [Yahoo! Finance]
Low
Report
AbCellera Biologics (ABCL) Pivots to Clinical Stage as 2025 Revenue Hits $75M [Yahoo! Finance]
2/25
12:14 am
abcl
AbCellera Biologics Inc (ABCL) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges [Yahoo! Finance]
Medium
Report
AbCellera Biologics Inc (ABCL) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges [Yahoo! Finance]
2/24
06:47 pm
abcl
AbCellera Biologics Q4 Earnings Call Highlights [Yahoo! Finance]
Medium
Report
AbCellera Biologics Q4 Earnings Call Highlights [Yahoo! Finance]
2/24
04:05 pm
abcl
AbCellera Reports Full Year 2025 Business Results
Medium
Report
AbCellera Reports Full Year 2025 Business Results
2/14
01:32 am
abcl
AbCellera Biologics (NASDAQ:ABCL) was upgraded by analysts at
Wall Stree
Low
Report
AbCellera Biologics (NASDAQ:ABCL) was upgraded by analysts at
Wall Stree
2/11
04:05 pm
abcl
AbCellera to Present at Upcoming Investor Conferences in March and April 2026
Medium
Report
AbCellera to Present at Upcoming Investor Conferences in March and April 2026
2/5
11:07 am
abcl
Short sales on the TSX: Where are the sellers as software stocks tumble? [Globe and Mail, The (Toronto, Canada)]
Medium
Report
Short sales on the TSX: Where are the sellers as software stocks tumble? [Globe and Mail, The (Toronto, Canada)]
2/2
07:54 pm
abcl
AbCellera Biologics Inc. (ABCL): A Bull Case Theory [Yahoo! Finance]
Low
Report
AbCellera Biologics Inc. (ABCL): A Bull Case Theory [Yahoo! Finance]
1/30
01:42 am
abcl
Reassessing AbCellera Biologics (ABCL) After A Sharp 16.8% Weekly Share Price Drop [Yahoo! Finance]
Medium
Report
Reassessing AbCellera Biologics (ABCL) After A Sharp 16.8% Weekly Share Price Drop [Yahoo! Finance]
1/22
04:05 pm
abcl
AbCellera to Report Full Year 2025 Financial Results on February 24, 2026
Medium
Report
AbCellera to Report Full Year 2025 Financial Results on February 24, 2026
1/20
01:25 am
abcl
AbCellera Biologics (NASDAQ:ABCL) was downgraded by analysts at
Wall Str
Low
Report
AbCellera Biologics (NASDAQ:ABCL) was downgraded by analysts at
Wall Str
1/14
08:21 pm
abcl
AbCellera Biologics Pivots to Internal Pipeline at JPMorgan, Teases Key Milestones for 2026 [Yahoo! Finance]
Medium
Report
AbCellera Biologics Pivots to Internal Pipeline at JPMorgan, Teases Key Milestones for 2026 [Yahoo! Finance]
1/12
09:26 am
abcl
AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause [Yahoo! Finance]
Low
Report
AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause [Yahoo! Finance]
1/12
09:00 am
abcl
AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause
Low
Report
AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause
1/12
01:05 am
abcl
AbCellera Biologics (NASDAQ:ABCL) was upgraded by analysts at
Wall Stree
Low
Report
AbCellera Biologics (NASDAQ:ABCL) was upgraded by analysts at
Wall Stree
1/4
01:06 am
abcl
AbCellera Biologics (NASDAQ:ABCL) was downgraded by analysts at
Wall Str
Low
Report
AbCellera Biologics (NASDAQ:ABCL) was downgraded by analysts at
Wall Str
12/27
01:05 am
abcl
AbCellera Biologics (NASDAQ:ABCL) was upgraded by analysts at
Wall Stree
Medium
Report
AbCellera Biologics (NASDAQ:ABCL) was upgraded by analysts at
Wall Stree
12/25
07:00 pm
abcl
We're Not Worried About AbCellera Biologics' (NASDAQ:ABCL) Cash Burn [Yahoo! Finance]
Medium
Report
We're Not Worried About AbCellera Biologics' (NASDAQ:ABCL) Cash Burn [Yahoo! Finance]